141 related articles for article (PubMed ID: 33545223)
1. Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells.
Fawal MA; Jungas T; Davy A
Cancer Lett; 2021 Apr; 503():129-137. PubMed ID: 33545223
[TBL] [Abstract][Full Text] [Related]
2. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
3. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
4. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
5. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
[TBL] [Abstract][Full Text] [Related]
6. Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase.
Wang Y; Lu H; Sun L; Chen X; Wei H; Suo C; Feng J; Yuan M; Shen S; Jia W; Wang Y; Zhang H; Li Z; Zhong X; Gao P
Cell Death Dis; 2021 Oct; 12(10):902. PubMed ID: 34601503
[TBL] [Abstract][Full Text] [Related]
7. CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells.
Mukherjee S; Tucker-Burden C; Kaissi E; Newsam A; Duggireddy H; Chau M; Zhang C; Diwedi B; Rupji M; Seby S; Kowalski J; Kong J; Read R; Brat DJ
Cell Rep; 2018 May; 23(6):1651-1664. PubMed ID: 29742423
[TBL] [Abstract][Full Text] [Related]
8. ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.
Xing Y; Ge Y; Liu C; Zhang X; Jiang J; Wei Y
Oncotarget; 2016 Jun; 7(24):36395-36406. PubMed ID: 27119230
[TBL] [Abstract][Full Text] [Related]
9. DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide.
Zhao M; Tan B; Dai X; Shao Y; He Q; Yang B; Wang J; Weng Q
Eur J Pharmacol; 2019 Nov; 863():172665. PubMed ID: 31542479
[TBL] [Abstract][Full Text] [Related]
10. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
[TBL] [Abstract][Full Text] [Related]
12. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
14. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB
Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
Lin Y; Sun H; Dang Y; Li Z
Oncol Rep; 2018 Feb; 39(2):687-694. PubMed ID: 29251326
[TBL] [Abstract][Full Text] [Related]
16. Disparate Response to Methotrexate in Stem Versus Non-Stem Cells.
Beane OS; Darling LE; Fonseca VC; Darling EM
Stem Cell Rev Rep; 2016 Jun; 12(3):340-51. PubMed ID: 26815725
[TBL] [Abstract][Full Text] [Related]
17. SPY1-mediated symmetric cell division promotes BTIC self-renewal.
Cancer Discov; 2014 Mar; 4(3):OF11. PubMed ID: 24596205
[TBL] [Abstract][Full Text] [Related]
18. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
19. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
20. Response-predictive gene expression profiling of glioma progenitor cells in vitro.
Moeckel S; Meyer K; Leukel P; Heudorfer F; Seliger C; Stangl C; Bogdahn U; Proescholdt M; Brawanski A; Vollmann-Zwerenz A; Riemenschneider MJ; Bosserhoff AK; Spang R; Hau P
PLoS One; 2014; 9(9):e108632. PubMed ID: 25268354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
